Home
About
Overview
Sharing Data
ORCID
Help
History (22)
Biological alterations in the primary affective disorders and other tricyclic-responsive disorders.
Silver Staining
Runx1 is a co-activator with FOXO3 to mediate transforming growth factor beta (TGFbeta)-induced Bim transcription in hepatic cells.
The role of eicosanoids in mediating blood flow alterations in endotoxin shock.
Anti-relapse medications: preclinical models for drug addiction treatment.
See All 22 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Anti-relapse medications: preclinical models for drug addiction treatment.
Anti-relapse medications: preclinical models for drug addiction treatment. Pharmacol Ther. 2009 Nov; 124(2):235-47.
View in:
PubMed
subject areas
Animals
Behavior, Addictive
Controlled Clinical Trials as Topic
Disease Models, Animal
Dopamine Agents
Humans
Secondary Prevention
Substance-Related Disorders
authors with profiles
Ronald E See